-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Nuvation Bio, Maintains $21 Price Target

Benzinga·11/17/2026 12:12:40
Listen to the news
HC Wainwright & Co. analyst Robert Burns reiterates Nuvation Bio (NYSE:NUVB) with a Buy and maintains $21 price target.